Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Jul 10, 2021 11:52am
146 Views
Post# 33526639

RE:RE:Weekly Report Card

RE:RE:Weekly Report Card

"The simplest way I can put it is it’s giving the customer what they ask for, not what you want to give them…even when they don’t know quite how to ask for what they mean."
 

This quote says it all, to add to it I would say sometimes the customers don't even know what they want to get motivated for instance although off topics if one build a house and has a sizeable back yard adding a low cost barbecue station or a stationary Gazebo can do magic to  the potential buyer as everyone love their home and outdoor activities within their home.
That's why a salesman has to be one step ahead of their customers. 

 

Wino115 wrote:

I, like SPCEO, am a fundamental investor -I think the value of that stock certificate should be highly related to the forward looking  financial returns the assets it represents make in a probabilistic and discounted way taking into account all the risks and opportunities.   I think many of you on this board are. We are frustrated because the fundamentals for THTX are very good, making low investments in assets with potentially spectacular returns even with huge discounts rates for the risk. But the issues we've all identified contribute to it being ignored and maybe, or maybe not, fairly reflecting the assets and permutations of return patterns on those assets.  Scarlet, in particular, has identified the fact this is a different market with different investor valuing companies at the margin.  

I found this quick read that offers up an analogy to explain why fundamentals mean less. It's a hard nut to crack but in biotech, we at least have highly meaningful mileposts that history shows really injects the fundamental picture immediately. These will do the trick if positive. The signs so far are good. Hopefully we can learn something next week to help this equation along. 

https://www.iansbnr.com/how-moneyball-ruined-baseball/

 



<< Previous
Bullboard Posts
Next >>